The Claim
In human mesothelioma (P31) cells, but not in colon carcinoma (HT29) cells, increasing glutathione peroxidase activity through 100 nM selenite supplementation results in a small but significant reduction in DNA single-strand breaks caused by low-dose t-butyl hydroperoxide (10–50 µM), demonstrating a cell line-specific response to organic hydroperoxides.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In laboratory-grown human cancer cells, adding a specific form of selenium reduces DNA damage from a chemical oxidant in one type of cell (mesothelioma) but not in another (colon cancer), showing that different cancer cells respond differently to the same treatment.
See the scientific wording
In human mesothelioma (P31) cells, but not colon carcinoma (HT29) cells, increasing glutathione peroxidase activity via 100 nM selenite supplementation leads to a small but significant reduction in DNA single-strand breaks induced by low-dose t-butyl hydroperoxide (10–50 µM), indicating cell line-specific responses to organic hydroperoxides.
What the research says
1 studyIn simple terms, adding a small amount of selenium made one type of cancer cell (P31) better at protecting its DNA from damage caused by a chemical, but it didn’t help the other type (HT29). This shows that different cancer cells respond differently to the same treatment.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.